McKesson Corporation (NYSE:MCK) today announced a three-year extension of its existing distribution agreement with CVS Caremark through June, 2019.
“We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
“We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” said Paul Julian, executive vice president, group president, McKesson Corporation. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit www.mckesson.com.
Erin Lampert, 415-983-8391 (Investors and Financial Media)